OYST - Oyster Point Pharma Inc. (OYST) CEO Jeffrey Nau on Q1 2021 Results - Earnings Call Transcript
Oyster Point Pharma, Inc. (OYST) Q1 2021 Earnings Conference Call May 06, 2021 4:30 PM ET Company Participants Daniel Lochner - Chief Financial Officer Jeffrey Nau - President and Chief Executive Officer John Snisarenko - Chief Commercial Officer Conference Call Participants Ken Cacciatore - Cowen & Company Tessa Romero - JPMorgan Joseph Catanzaro - Piper Sandler Patrick Dolezal - LifeSci Capital Presentation Operator Good evening, and welcome to Oyster Point Pharma's First Quarter 2021 Earnings Conference Call. My name is Sarah, and I will be your operator today. After the company's formal remarks, there will be a question-and-answer session. At this time, I would like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma's Chief Financial Officer. Please go ahead. Daniel Lochner Good evening, everyone, and welcome to the Oyster Point Pharma First quarter earnings conference call for the 3 months ending March 31, 2021. This evening,
For further details see:
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q1 2021 Results - Earnings Call Transcript